SCHEMBL1895869

SCHEMBL1895869

[c]1ccc(OC2CCN(Cc3ccccc3)CC2)cc1

nearest known ligand 0.69

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.69
SMN1; SMN2 Q16637 2/20 0.64
GAA P10253 1/20 0.64
OPRK1 P41145 1/20 0.55
ROCK1 Q13464 2/20 0.54
ROCK2 O75116 1/20 0.54
CCR2 P41597 1/20 0.54
ACHE P22303 1/20 0.51
CCR3 P51677 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
CARM1 Q86X55 1/20 0.49
PRMT6 Q96LA8 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
BCHE P06276 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4855546 0.89 HRH3 (0.74) HRH3SMN1; SMN2GAAOPRK1ROCK1
SCHEMBL8393625 0.84 HRH3 (0.71) HRH3SMN1; SMN2GAAOPRK1ROCK1
SCHEMBL3022526 0.84 HRH3 (0.71) HRH3SMN1; SMN2GAAOPRK1ROCK1
SCHEMBL4125911 0.82 HRH3 (0.65) HRH3SMN1; SMN2GAAOPRK1ROCK1
SCHEMBL5203366 0.82 HRH3 (0.69) HRH3SMN1; SMN2GAAOPRK1ROCK1
SCHEMBL10605326 0.82 HRH3 (0.69) HRH3SMN1; SMN2GAAOPRK1ROCK1
SCHEMBL13450155 0.82 SMN1; SMN2 (0.71) HRH3SMN1; SMN2GAAOPRK1ROCK1
SCHEMBL4227981 0.82 HRH3 (1.00) HRH3SMN1; SMN2GAAOPRK1ROCK1
Hydrochloric Acid SCHEMBL10605533 0.81 SMN1; SMN2 (0.70) HRH3SMN1; SMN2GAAOPRK1ROCK1
SCHEMBL13463052 0.81 HRH3 (0.70) HRH3SMN1; SMN2GAAOPRK1ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493571-A1 ALKYNYL DERIVATIVES USEFUL AS DPP-1 INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2012-09-05 EP disclosed
WO-2011059731-A1 ALKYNYL DERIVATIVES USEFUL AS DPP-1 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2011-05-19 WO disclosed